Press release
Orphan Drugs Market By Size, Supplier, Demand Analysis, Type, Statistics, Regions and Forecast – 2030
Prophecy Market Insights
The report " Global Orphan Drugs Market, By Drug Type (Biological and Non- Biological), By Top Selling Drugs (Revlimid, Rituxan, Copaxone, Opdivo, Keytruda, Imbruvica, Avonex, Sensipar, Soliris, and Other Top Selling Drugs), By Disease Type (Oncology, Hematology, Neurology, Cardiovascular, and Other Disease Types), By Phase (Phase I, Phase II, Phase III, and Phase IV), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”
Access Full Report@
https://www.prophecymarketinsights.com/market_insight/Global-Orphan-Drugs-Market-By-3793
Drivers:
Governments in various countries have made significant investments in projects associated with the sector of synthetic biology and genomics. These government investments have played a serious role within the development of latest technologies. Oligos form an integral a part of these technologies, and increasing funding & developments in these fields will drive market growth for oligonucleotides. For instance, In January 2020, the Department of Biotechnology (DBT) initiated the “Genome India Project” (GIP). The project aims to gather 10,000 genetic samples from citizens across India to create a reference genome. Some focus areas of this project are precision health, rare genetic disorders, mutation spectrum of genetic & complex diseases within the Indian population, genetic epidemiology of multifactorial lifestyle diseases, and translational research.
Restrains:
The importance of synthetic Oligos as therapeutic drugs for treating diseases has grown significantly within the last decade. However, there are various instances within the past, wherein due to high complexities like severe side effects, many drugs are withdrawn or have failed in clinical test phases. Such instances could become recurrent and should restrain market growth to a particular extend.
Download Free sample copy of this report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3793
Key Market Insights from the report:
The Global Orphan Drugs Market accounted for US$ 5.5 billion in 2020 and is estimated to be US$ 26.4 billion by 2030 and is anticipated to register a CAGR of 16.9%. The Global Orphan Drugs Market is segmented based on the Product type, type, application and region.
• By Product Type, the Global Orphan Drugs Market is segmented into Synthesized Oligonucleotide Product, Reagents and Equipment.
• By Type, the Global Orphan Drugs Market is segmented into Custom Oligos and Predesigned Oligos.
• By Application, the Global Orphan Drugs Market is segmented into Research, Diagnostics, and Therapeutics.
• By region, the Global Orphan Drugs Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the worldwide leader in the Orphan Drugs market in terms of revenue, due to the developed healthcare system and health awareness among people.
Competitive Landscape & their strategies:
The key players operating the global Orphan Drugs market involves Agilent Technologies, Inc., ATDBio Ltd., Bio-Synthesis, Inc., BioAutomation Corporation, LGC Biosearch Technologies, Biogen International, Sarepta Therapeutics, Eurofins Genomics, Eurogentec, GeneDesign, Inc., GE Healthcare, and GenScript, Inc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.
About Report:
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Explore Extensive Coverage of Prophecy Market Insights Healthcare Industry:
Related Reports:
Global E-Pharmacy Market
https://www.prophecymarketinsights.com/market_insight/Global-EPharmacy-Market-By-Drug-35
Global Preventive Asthma Drugs Market
https://www.prophecymarketinsights.com/market_insight/Global-Preventive-Asthma-Drugs-Market-40
Key questions answered in the report:
• What will the market growth rate of Orphan Drugs Market in 2030?
• What are the key factors driving the global Orphan Drugs Market?
• Who are the key manufacturers in Orphan Drugs Market space?
• What are the market opportunities, market risk and market overview of the Global Orphan Drugs market?
• What are sales, revenue, and price analysis of top manufacturers of Orphan Drugs Global market?
• What are sales, revenue, and price analysis by types and applications of Orphan Drugs Market?
• What are sales, revenue, and price analysis by regions of Orphan Drugs market?
To know more
Contact Us:
Sales
Prophecy Market Insights
+1 860 531 2701
Email- sales@prophecymarketinsights.com
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drugs Market By Size, Supplier, Demand Analysis, Type, Statistics, Regions and Forecast – 2030 here
News-ID: 2367037 • Views: …
More Releases from Prophecy Market Insights
Power Purchase Agreement (PPA) Market Poised for Strong Growth Amid Rising Renew …
Author: Shweta R., Business Development Specialist | Prophecy Market Insights
Introduction
The Power Purchase Agreement (PPA) Market is experiencing remarkable momentum, driven by the global transition toward renewable energy, carbon reduction targets, and rising demand for cost-effective electricity procurement models.
PPAs-long-term contracts between electricity producers and buyers-are becoming a critical mechanism for corporations, utilities, and governments to achieve energy security, price stability, and sustainability commitments. With the accelerating deployment of solar, wind, and…
Nutraceutical Packaging Market to Witness Robust Growth Amid Rising Health and W …
Author: Shweta R., Business Development Specialist | Prophecy Market Insights
Introduction
The Nutraceutical Packaging Market is witnessing significant growth, fueled by rising consumer awareness around health, nutrition, and preventive healthcare. Nutraceuticals-ranging from dietary supplements and functional foods to vitamins, minerals, and herbal products-require specialized packaging that ensures shelf life, product integrity, safety, and consumer appeal.
With increasing demand for convenient, eco-friendly, and innovative packaging solutions, companies are investing in advanced materials, smart labeling,…
Japan Regulatory Affairs Outsourcing Market Set to Reach USD 0.4 Billion by 2035 …
Pune, India - September 5, 2025 - The Japan Regulatory Affairs Outsourcing Market is witnessing steady growth as pharmaceutical, biotechnology, and medical device companies increasingly rely on external partners for regulatory compliance. By 2035, the market is projected to reach USD 0.4 billion, rising from USD 0.3 billion in 2025, expanding at a CAGR of 7.71% during the forecast period.
Get a Sample Copy of Report :- https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5849
This growing demand underscores…
Europe Regulatory Affairs Outsourcing Market to Reach USD 4.2 Billion by 2035, D …
Pune, India - September 2, 2025 - The Europe Regulatory Affairs Outsourcing Market is experiencing steady growth as pharmaceutical, biotechnology, and medical device companies increasingly rely on specialized partners for regulatory compliance. According to recent analysis, the market size was valued at USD 2.0 billion in 2025 and is projected to expand to USD 4.2 billion by 2035, registering a CAGR of 7.70% during the forecast period.
Get Sample Copy of…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
